Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis
The DOI matches its Crossref record; 24 of the 25 references it cites were found in a registry or an index.
Abstract
Hereditary hemochromatosis is a prevalent genetic disorder of iron hyperabsorption leading to hyperferremia, tissue iron deposition and complications including cirrhosis, hepatocarcinoma, cardiomyopathy and diabetes. Most individuals affected with hereditary hemochromatosis are homozygous with respect to a missense mutation that disrupts the conformation of HFE, an atypical HLA class I molecule (ref. 1; OMIM 235200). Mice lacking Hfe or producing a C282Y mutant Hfe protein develop hyperferremia and have high hepatic iron levels. In both humans and mice, hereditary hemochromatosis is associated with a paucity of iron in reticuloendothelial cells. It has been suggested that HFE modulates uptake of transferrin-bound iron by undifferentiated intestinal crypt cells, thereby programming the absorptive capacity of enterocytes derived from these cells; however, this model is unproven and controversial. Hepcidin, a peptide hormone (HAMP; OMIM 606464), seems to act in the same regulatory pathway as HFE. Although expression of mouse Hamp is normally greater during iron overload, Hfe-/- mice have inappropriately low expression of Hamp. We crossed Hfe-/- mice with transgenic mice overexpressing Hamp and found that Hamp inhibited the iron accumulation normally observed in the Hfe-/- mice. This argues against the crypt programming model and suggests that failure of Hamp induction contributes to the pathogenesis of hemochromatosis, providing a rationale for the use of HAMP in the treatment of this disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thus, transgenic expression of hepcidin prevented iron overload in Hfe−∕− (Nicolas et al., 2003) and Hbbth3∕+ (Gardenghi et al., 2010) mice, models of HH and β-thalassemia intermedia, respectively.”
From Pharmacological Targeting of the Hepcidin/Ferroportin Axis (2016) · cites this paper as Nicolas et al., 2003
Citations
Cites
A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
Feder, J. N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D. A., Basava, A., Dormishian, F., Domingo, R., Ellis, M. C., Fullan, A., et al. (1996) · Nature Genetics · doi:10.1038/ng0896-399 · Cited by 3,664 · cited 1×
“Most individuals affected with hereditary hemochromatosis are homozygous with respect to a missense mutation that disrupts the conformation of HFE, an atypical HLA class I molecule (ref”
BackgroundHepcidin, a urinary antimicrobial peptide synthesized in the liver
Park, C. H., Valore, E. V., Waring, A. J., & Ganz, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008922200 · Cited by 2,168
Pigeon, C., Ilyin, G., Courselaud, B., Leroyer, P., Turlin, B., Brissot, P., & Loréal, O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008923200 · Cited by 1,697 · cited 1×
“It is synthesized predominantly in the liver, secreted as peptides of 20–25 amino acid”
BackgroundHepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein
Nemeth, E., Valore, E. V., Territo, M., Schiller, G., Lichtenstein, A., & Ganz, T. (2003) · Blood · doi:10.1182/blood-2002-10-3235 · Cited by 1,417 · cited 1×
“Other individuals with anemia and inflammation have been reported with elevated urinary HAMP excretio”
BackgroundLEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity
Krause, A., Neitz, S., Mägert, H.-J., Schulz, A., Forssmann, W.-G., Schulz-Knappe, P., & Adermann, K. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01920-7 · Cited by 1,324
Nicolas, G., Bennoun, M., Devaux, I., Beaumont, C., Grandchamp, B., Kahn, A., & Vaulont, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151179498 · Cited by 1,233
Self-citationNicolas, G., Chauvet, C., Viatte, L., Danan, J. L., Bigard, X., Devaux, I., Beaumont, C., Kahn, A., & Vaulont, S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215686 · Cited by 1,214 · cited 1×
“Hamp -deficient mice are unresponsive to the hypoferremic effects of inflammation provoked by turpentine injectio”
BackgroundSelf-citationSevere iron deficiency anemia in transgenic mice expressing liver hepcidin
Nicolas, G., Bennoun, M., Porteu, A., Mativet, S., Beaumont, C., Grandchamp, B., Sirito, M., Sawadogo, M., Kahn, A., & Vaulont, S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.072632499 · Cited by 880
Self-citationMutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis
Roetto, A., Papanikolaou, G., Politou, M., Alberti, F., Girelli, D., Christakis, J., Loukopoulos, D., & Camaschella, C. (2003) · Nature Genetics · doi:10.1038/ng1053 · Cited by 860 · cited 1×
“Recently, humans with severe hemochromatosis have been shown to have null mutations in the gene HAMP”
BackgroundWeinstein, D. A., Roy, C. N., Fleming, M. D., Loda, M. F., Wolfsdorf, J. I., & Andrews, N. C. (2002) · Blood · doi:10.1182/blood-2002-04-1260 · Cited by 632 · cited 1×
“Humans with constitutively active HAMP expression develop iron-refractory anemia associated with defective intestinal iron absorption and macrophage iron retention, similar to the anemia of chronic inflammatio”
BackgroundSelf-citation
Cited by
Nemeth, E., Rivera, S., Gabayan, V., Keller, C., Taudorf, S., Pedersen, B. K., & Ganz, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420945 · Cited by 2,650
“Even though the biological effects of hepcidin (4, 5, 28) strongly suggest it directly inhibits iron trans - port and recycling, the specific molecular pathways by which this is accomplished remain to be delineated.”
Two to tango: Regulation of Mammalian iron metabolism
Hentze, M. W., Muckenthaler, M. U., Galy, B., & Camaschella, C. (2010) · Cell · doi:10.1016/j.cell.2010.06.028 · Cited by 2,120
Hentze, M. W., Muckenthaler, M. U., & Andrews, N. C. (2004) · Cell · doi:10.1016/s0092-8674(04)00343-5 · Cited by 1,736
Self-citationThe iron exporter ferroportin/Slc40a1 is essential for iron homeostasis
Donovan, A., Lima, C. A., Pinkus, J. L., Pinkus, G. S., Zon, L. I., Robine, S., & Andrews, N. C. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.01.003 · Cited by 1,275
“…either resulting from mutations in hepcidin itself or from mutations in genes that must, in some way, control hepcidin expression (Bridle et al., 2003; Kawabata et al., 2005; Muckenthaler et al., 2003; Nemeth et al., 2005; Nicolas et al., 2003; Papanikolaou et al., 2004; Roetto et al., 2003).”
BackgroundSelf-citationGanz, T. (2013) · Physiological Reviews · doi:10.1152/physrev.00008.2013 · Cited by 1,122
“Hepcidin production is inappropriately low in most forms of hereditary hemochromatosis (89, 113, 137, 163, 166, 169, 170, 177, 178, 204, 256, 261) and certain iron-loading anemias, including -thalassemia (2, 21, 85, 160, 174, 178) and congenital dyserythropoietic anemias (32, 125, 236).”
BackgroundDorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism
Yu, P. B., Hong, C. C., Sachidanandan, C., Babitt, J. L., Deng, D. Y., Hoyng, S. A., Lin, H. Y., Bloch, K. D., & Peterson, R. T. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.2007.54 · Cited by 1,034
Hereditary Hemochromatosis — A New Look at an Old Disease
Pietrangelo, A. (2004) · New England Journal of Medicine · doi:10.1056/nejmra031573 · Cited by 992
Hepcidin and iron regulation, 10 years later
Ganz, T. (2011) · Blood · doi:10.1182/blood-2011-01-258467 · Cited by 962
Schaible, U. E., & Kaufmann, S. H. E. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro1046 · Cited by 945
“Hepcidin plays a part in this process as the levels of this molecule in HFE-deficient mice are also low, and overexpression of hepcidin in these mice corrects haematochromatosi”
Regulation of Iron Metabolism by Hepcidin
Nemeth, E., & Ganz, T. (2006) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.26.061505.111303 · Cited by 756
Muckenthaler, M. U., Galy, B., & Hentze, M. W. (2008) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.28.061807.155521 · Cited by 701
Characterization of ferroptosis in murine models of hemochromatosis
Wang, H., An, P., Xie, E., Wu, Q., Fang, X., Gao, H., Zhang, Z., Li, Y., Wang, X., Zhang, J., et al. (2017) · Hepatology · doi:10.1002/hep.29117 · Cited by 660
“S2A and B) due to impaired hepcidin expression in the liver (24-26).”
Forging a field: the golden age of iron biology.
Andrews, N. C. (2008) · Blood · doi:10.1182/blood-2007-12-077388 · Cited by 623
Self-citationThe Role of Hepcidin in Iron Metabolism
Nemeth, E., & Ganz, T. (2009) · Acta Haematologica · doi:10.1159/000243791 · Cited by 607
STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation
Verga Falzacappa, M. V., Vujic Spasic, M., Kessler, R., Stolte, J., Hentze, M. W., & Muckenthaler, M. U. (2007) · Blood · doi:10.1182/blood-2006-07-033969 · Cited by 567
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
“In the liver and elsewhere, many aspects of iron metabolism are regulated by a recently discovered 25amino acid polypeptide called hepcidin [163; 186; 190; 212; 230-255] that acts in part as a negative regulator of iron efflux [256] by causing the internalisation of ferroportin [257-261].”
BackgroundArredondo, M., & Núñez, M. T. (2005) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2005.07.010 · Cited by 550
“mortality due to severe microcytic hypochromic anemia (Nicolas et al., 2003).”
BackgroundKnutson, M. D., Oukka, M., Koss, L. M., Aydemir, F., & Wessling-Resnick, M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409409102 · Cited by 479
Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance
Babitt, J. L., Huang, F. W., Xia, Y., Sidis, Y., Andrews, N. C., & Lin, H. Y. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31342 · Cited by 457
Hepcidin—a regulator of intestinal iron absorption and iron recycling by macrophages
GANZ, T. (2005) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2004.08.020 · Cited by 393
The role of iron in type 2 diabetes in humans
Rajpathak, S. N., Crandall, J. P., Wylie-Rosett, J., Kabat, G. C., Rohan, T. E., & Hu, F. B. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.04.005 · Cited by 363
Liver iron sensing and body iron homeostasis
Wang, C.-Y., & Babitt, J. L. (2019) · Blood · doi:10.1182/blood-2018-06-815894 · Cited by 360
Molecular control of iron transport
Ganz, T. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006070802 · Cited by 353
“In further support of the central involvement of hepcidin in the pathogenesis of hemochromatosis, transgenic correction of hepcidin deficiency in a mouse model of HFE hemochromatosis prevents the development of iron overload pathology (56).”
BackgroundIron imports. IV. Hepcidin and regulation of body iron metabolism
Ganz, T., & Nemeth, E. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00412.2005 · Cited by 347
“Moreover, in the mouse model of HFE hemochromatosis, correction of the defect is achieved by overexpression of hepcidin 1 (17).”
The Transferrin Receptor Modulates Hfe-Dependent Regulation of Hepcidin Expression
Schmidt, P. J., Toran, P. T., Giannetti, A. M., Bjorkman, P. J., & Andrews, N. C. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.11.016 · Cited by 345
Self-citationGao, J., Chen, J., Kramer, M., Tsukamoto, H., Zhang, A.-S., & Enns, C. A. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.01.010 · Cited by 326
“…the reports that hepcidin levels are lower in Hfe / and in Tfr2 mutant mice (Ahmad et al., 2002; Bridle et al., 2003; Muckenthaler et al., 2003; Nicolas et al., 2003; Wallace et al., 2007), the hepcidin mRNA levels in the isolated primary hepatocytes from Hfe / and Tfr2245X/245X mice were…”
BackgroundResultHepcidin: from discovery to differential diagnosis
Kemna, E. H. J. M., Tjalsma, H., Willems, H. L., & Swinkels, D. W. (2008) · Haematologica · doi:10.3324/haematol.11705 · Cited by 313
Gardenghi, S., Marongiu, M. F., Ramos, P., Guy, E., Breda, L., Chadburn, A., Liu, Y., Amariglio, N., Rechavi, G., Rachmilewitz, E. A., et al. (2007) · Blood · doi:10.1182/blood-2006-09-048868 · Cited by 313
Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis
Merryweather-Clarke, A. T. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg225 · Cited by 263
“The natural mutations and phenotypes observed in our patients are proof of predictions made from mouse models of haemochromatosis that genetic variablility in HAMP might contribute to the wide range in phenotypic variation in HFE C282Y homozygotes (21,22).”
Hepcidin and Its Role in Regulating Systemic Iron Metabolism
Ganz, T. (2006) · Hematology · doi:10.1182/asheducation-2006.1.29 · Cited by 259
Kulaksiz, H., Gehrke, S. G., Janetzko, A., Rost, D., Bruckner, T., Kallinowski, B., & Stremmel, W. (2004) · Gut · doi:10.1136/gut.2003.022863 · Cited by 247
“and constitutive hepcidin expression prevented iron overload in a mouse model of haemochromatosis,”
BackgroundKawabata, H., Fleming, R. E., Gui, D., Moon, S. Y., Saitoh, T., O'Kelly, J., Umehara, Y., Wano, Y., Said, J. W., & Koeffler, H. P. (2005) · Blood · doi:10.1182/blood-2004-04-1416 · Cited by 239
Preza, G. C., Ruchala, P., Pinon, R., Ramos, E., Qiao, B., Peralta, M. A., Sharma, S., Waring, A., Ganz, T., & Nemeth, E. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57693 · Cited by 234
“The proof of this concept was achieved in mouse model of HFE hereditary hemochromatosis, in which the introduction of a hepcidin transgene into Hfe–/– mice prevented the development of iron overload (33).”
BackgroundMolecular Mechanisms of Hepcidin Regulation: Implications for the Anemia of CKD
Babitt, J. L., & Lin, H. Y. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.12.030 · Cited by 235
Regulation of iron acquisition and iron distribution in mammals
Ganz, T., & Nemeth, E. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.03.014 · Cited by 235
Iron, Free Radicals, and Oxidative Injury
McCord, J. M. (2004) · The Journal of Nutrition · doi:10.1093/jn/134.11.3171s · Cited by 233
Anderson, E. R., & Shah, Y. M. (2013) · Comprehensive Physiology · doi:10.1002/cphy.c120016 · Cited by 219
Hepcidin Revisited, Disulfide Connectivity, Dynamics, and Structure
Jordan, J. B., Poppe, L., Haniu, M., Arvedson, T., Syed, R., Li, V., Kohno, H., Kim, H., Schnier, P. D., Harvey, T. S., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.017764 · Cited by 214
Schmidt, P. J., Toudjarska, I., Sendamarai, A. K., Racie, T., Milstein, S., Bettencourt, B. R., Hettinger, J., Bumcrot, D., & Fleming, M. D. (2013) · Blood · doi:10.1182/blood-2012-09-453977 · Cited by 204
Regulation of transferrin receptor 2 protein levels by transferrin
Robb, A., & Wessling-Resnick, M. (2004) · Blood · doi:10.1182/blood-2004-06-2481 · Cited by 203
D’Alessio, F., Hentze, M. W., & Muckenthaler, M. U. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.06.015 · Cited by 200
“These mutations result in inappropriately low hepcidin levels, reflecting activation of hepcidin expression by HFE, TfR2, and HJV [9–11].”
BackgroundIron Regulation: Macrophages in Control
Sukhbaatar, N., & Weichhart, T. (2018) · Pharmaceuticals · doi:10.3390/ph11040137 · Cited by 200
Anemia of inflammation: the hepcidin link
Roy, C. N., & Andrews, N. C. (2005) · Current Opinion in Hematology · doi:10.1097/00062752-200503000-00001 · Cited by 200
Understanding iron homeostasis through genetic analysis of hemochromatosis and related disorders
Camaschella, C. (2005) · Blood · doi:10.1182/blood-2005-05-1857 · Cited by 199
Iron regulation and erythropoiesis
Nemeth, E. (2008) · Current Opinion in Hematology · doi:10.1097/moh.0b013e3282f73335 · Cited by 181
Zhang, A.-S., Xiong, S., Tsukamoto, H., & Enns, C. A. (2004) · Blood · doi:10.1182/blood-2003-07-2378 · Cited by 174
Regulation of Hepcidin and Iron-Overload Disease
Lee, P. L., & Beutler, E. (2009) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092205 · Cited by 174
“Crossing hepcidin-transgenic mice with Hfe−/− mice has been found to inhibit iron accumulation in Hfe−/− mice (39).”
BackgroundInhibition of bone morphogenetic protein signaling attenuates anemia associated with inflammation
Steinbicker, A. U., Sachidanandan, C., Vonner, A. J., Yusuf, R. Z., Deng, D. Y., Lai, C. S., Rauwerdink, K. M., Winn, J. C., Saez, B., Cook, C. M., et al. (2011) · Blood · doi:10.1182/blood-2010-10-313064 · Cited by 173
The Regulation of Cellular Iron Metabolism
Chua, A. C. G., Graham, R. M., Trinder, D., & Olynyk, J. K. (2007) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360701428257 · Cited by 168
Ganz, T. (2004) · Current Opinion in Hematology · doi:10.1097/00062752-200407000-00004 · Cited by 166
Jacolot, S., Le Gac, G., Scotet, V., Quere, I., Mura, C., & Ferec, C. (2004) · Blood · doi:10.1182/blood-2003-10-3366 · Cited by 165
Review article: the iron overload syndromes
Siddique, A., & Kowdley, K. V. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2012.05051.x · Cited by 162
“Moreover, when Hfe / mice were crossed with transgenic mice that over express hepcidin, there was prevention of the iron overload phenotype, implicating an overriding role of hepcidin in iron homeostasis.(40) Furthermore, ablation of HFE expression in mouse enterocytes does not disrupt normal physiological iron metabo…”
BackgroundHFE gene: Structure, function, mutations, and associated iron abnormalities
Barton, J. C., Edwards, C. Q., & Acton, R. T. (2015) · Gene · doi:10.1016/j.gene.2015.10.009 · Cited by 161
“constitutive overexpression of the gene that encodes hepcidin (Hamp) [236].”
Hepcidin-ferroportin axis in health and disease
Ginzburg, Y. Z. (2019) · Vitamins and hormones · doi:10.1016/bs.vh.2019.01.002 · Cited by 186
“Four types of disorders exist, all of which result in increased intestinal iron absorption as a consequence of inadequate hepcidin, or hepcidin insensitivity, relative to the degree of systemic iron (Bridle et al., 2003; Muckenthaler et al., 2003; Nicolas et al., 2003).”
BackgroundHfe Acts in Hepatocytes to Prevent Hemochromatosis
Spasić, M. V., Kiss, J., Herrmann, T. R. W., Galy, B., Martinache, S., Stolte, J., Gröne, H., Stremmel, W., Hentze, M. W., & Muckenthaler, M. U. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.11.014 · Cited by 165
Lactoferrin: Role in iron homeostasis and host defense against microbial infection
Ward, P. P., & Conneely, O. M. (2004) · BioMetals · doi:10.1023/b:biom.0000027693.60932.26 · Cited by 169
“…strongly upregulated in response to iron loading (Pigeon et al. 2001) and inappropriate expression of this gene has been linked to iron disorders in mice and humans (Nicolas et al. 2001, Ahmad et al. 2002, Nicolas et al. 2002., Weinstein et al. 2002, Muckenthaler et al. 2003, Nicolas et al. 2003).”
BackgroundVerga Falzacappa, M. V., Casanovas, G., Hentze, M. W., & Muckenthaler, M. U. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0313-7 · Cited by 146
Nairz, M., Theurl, I., Schroll, A., Theurl, M., Fritsche, G., Lindner, E., Seifert, M., Crouch, M.-L. V., Hantke, K., Akira, S., et al. (2009) · Blood · doi:10.1182/blood-2009-05-223354 · Cited by 146
Pharmacological Targeting of the Hepcidin/Ferroportin Axis
Sebastiani, G., Wilkinson, N., & Pantopoulos, K. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00160 · Cited by 127
The pathophysiology and pharmacology of hepcidin
Ruchala, P., & Nemeth, E. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.01.004 · Cited by 140
“For example, overexpression of hepcidin in Hfe-/mice, a model of the most common form of human hereditary hemochromatosis, prevented liver iron overload normally seen in these mutants [43].”
BackgroundBone Morphogenetic Protein Signaling Is Impaired in an Hfe Knockout Mouse Model of Hemochromatosis
Corradini, E., Garuti, C., Montosi, G., Ventura, P., Andriopoulos, B., Lin, H. Y., Pietrangelo, A., & Babitt, J. L. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.06.057 · Cited by 142
Viatte, L., & Vaulont, S. (2009) · Biochimie · doi:10.1016/j.biochi.2009.06.012 · Cited by 166
Iron Imports. I. Intestinal iron absorption and its regulation
Frazer, D. M., & Anderson, G. J. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00220.2005 · Cited by 135
“(18) showed that iron loading in HFE-null mice could be corrected by constitutively expressing hepcidin, confirming that HFE acts upstream of hepcidin in the iron regulatory pathway and strengthening the case that the liver was the most likely site of HFE activity.”
BackgroundHepcidin agonists as therapeutic tools
Casu, C., Nemeth, E., & Rivella, S. (2018) · Blood · doi:10.1182/blood-2017-11-737411 · Cited by 128
Hepcidin: A Promising Therapeutic Target for Iron Disorders A Systematic Review
Liu, J. L., Sun, B., Yin, H.-J., & Liu, S. (2016) · Medicine · doi:10.1097/md.0000000000003150 · Cited by 156
“Mimi-hepcidin and Derivatives Hamp mutation would cause severe iron overload, and Hamp overexpression and hepcidin administration both diminished serum iron accumulation in mice, suggesting that increasing hepcidin level should be able to ameliorate iron overload in HH and b-thalassemia.(84,85) However, due to a short…”
BackgroundPietrangelo, A. (2004) · Hepatology · doi:10.1002/hep.20007 · Cited by 128
Hepcidin antagonists for potential treatments of disorders with hepcidin excess
Poli, M., Asperti, M., Ruzzenenti, P., Regoni, M., & Arosio, P. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00086 · Cited by 124
“The importance of hepcidin was conclusively demonstrated by the finding that transgenic mice overexpressing the peptide showed a severe and often lethal anemia (Nicolas et al., 2003).”
BackgroundInfluentialManipulation of the hepcidin pathway for therapeutic purposes
Fung, E., & Nemeth, E. (2013) · Haematologica · doi:10.3324/haematol.2013.084624 · Cited by 123
Functional differences between hepcidin 1 and 2 in transgenic mice
Lou, D.-Q., Nicolas, G., Lesbordes, J.-C., Viatte, L., Grimber, G., Szajnert, M.-F., Kahn, A., & Vaulont, S. (2004) · Blood · doi:10.1182/blood-2003-07-2524 · Cited by 123
“These sheets are antiparallel and the structure is stabilized by disulfide bridges (7-23, 10-22, 11-19) and H-bonds (8-22, 10-20, 12-18).”
BackgroundSelf-citationHepcidin – central regulator of iron metabolism
Atanasiu, V., Manolescu, B. N., & Stoian, I. A.-M. (2006) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2006.00772.x · Cited by 149
Applications of small molecule BMP inhibitors in physiology and disease
Hong, C. C., & Yu, P. B. (2009) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.10.021 · Cited by 121
“Individuals with this form of hemochromatosis have a markedly impaired ability to produce hepcidin, a master control hormone of iron homeostasis which negatively regulates the transport of iron from enterocytes and other iron-storing cells into the circulation [48–51], developing iron overload and multi-system organ f…”
BackgroundRoy, C. N., Custodio, Á. O., de Graaf, J., Schneider, S., Akpan, I. J., Montross, L. K., Sánchez, M., Gaudino, A., Hentze, M. W., Andrews, N. C., et al. (2004) · Nature Genetics · doi:10.1038/ng1350 · Cited by 128
“Hfe is known to be required for this induction in response to iron overloa”
Normal iron metabolism and the pathophysiology of iron overload disorders.
Siah, C. W., Ombiga, J., Adams, L. A., Trinder, D., & Olynyk, J. K. (2006) · PubMed Central · Cited by 171
Hereditary Hemochromatosis: Genetic Complexity and New Diagnostic Approaches
Swinkels, D. W., Janssen, M. C., Bergmans, J., & Marx, J. J. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2006.068684 · Cited by 117
“Sequence variations in HFE were shown to lead to inappropriately low concentrations of hepcidin, suggesting that HFE is involved upstream in the regulation of hepcidin expression (82, 83).”
BackgroundKatsarou, A., & Pantopoulos, K. (2018) · Pharmaceuticals · doi:10.3390/ph11040127 · Cited by 112
“Thus, iron overload was corrected when these animals were crossed with mice overexpressing transgenic hepcidin [54,55], or with Tmprss6-/- mice overexpressing endogenous hepcidin [56,57].”
BackgroundVitte, J., Davoult, B., Roblot, N., Mayer, M., Joshi, V., Courageot, S., Tronche, F., Vadrot, J., Moreau, M. H., Kemeny, F., et al. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63428-1 · Cited by 117
Young, M. F., Glahn, R. P., Ariza‐Nieto, M., Inglis, J., Olbina, G., Westerman, M. E., & O'Brien, K. O. (2008) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26589 · Cited by 127
BMP/Smad signaling is not enhanced in Hfe-deficient mice despite increased Bmp6 expression
Kautz, L., Meynard, D., Besson-Fournier, C., Darnaud, V., Al Saati, T., Coppin, H., & Roth, M.-P. (2009) · Blood · doi:10.1182/blood-2009-02-206771 · Cited by 111
Corradini, E., Schmidt, P. J., Meynard, D., Garuti, C., Montosi, G., Chen, S., Vukicevic, S., Pietrangelo, A., Lin, H. Y., & Babitt, J. L. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.07.044 · Cited by 109
Hepcidin: Iron-hormone and anti-microbial peptide
Falzacappa, M. V. V., & Muckenthaler, M. U. (2005) · Gene · doi:10.1016/j.gene.2005.07.020 · Cited by 124
Molecular control of iron metabolism
Andrews, N. C. (2005) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2004.10.004 · Cited by 130
Corradini, E., Rozier, M., Meynard, D., Odhiambo, A., Lin, H. Y., Feng, Q., Migas, M. C., Britton, R. S., Babitt, J. L., & Fleming, R. E. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.06.077 · Cited by 102
Hepcidin in Anemia and Inflammation in Chronic Kidney Disease
Malyszko, J., & Mysliwiec, M. (2007) · Kidney and Blood Pressure Research · doi:10.1159/000098522 · Cited by 100
“The hepcidin gene was overexpressed in livers of experimentally iron-loaded mice [ ,”
BackgroundHepcidin Is Down‐Regulated in Alcohol Loading
Ohtake, T., Saito, H., Hosoki, Y., Inoue, M., Miyoshi, S., Suzuki, Y., Fujimoto, Y., & Kohgo, Y. (2007) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2006.00279.x · Cited by 98
Pietrangelo, A. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.05.013 · Cited by 144
Interacting signals in the control of hepcidin expression
Darshan, D., & Anderson, G. J. (2009) · BioMetals · doi:10.1007/s10534-008-9187-y · Cited by 113
Gardenghi, S., Grady, R. W., & Rivella, S. (2010) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2010.08.003 · Cited by 95
Gender-related variations in iron metabolism and liver diseases
Harrison-Findik, D. D. (2010) · World Journal of Hepatology · doi:10.4254/wjh.v2.i8.302 · Cited by 109
Strain and gender modulate hepatic hepcidin 1 and 2 mRNA expression in mice
Courselaud, B., Troadec, M., Fruchon, S., Ilyin, G., Borot, N., Leroyer, P., Coppin, H., Brissot, P., Roth, M., & Loréal, O. (2004) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2003.11.003 · Cited by 107
“This hypothesis was reinforced by the correction of the iron overload phenotype of Hfe / animals by a constitutive expression of Hepc1 mRNA [27].”
MethodIneffective Erythropoiesis: Anemia and Iron Overload
Gupta, R., Musallam, K. M., Taher, A. T., & Rivella, S. (2018) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2017.11.009 · Cited by 90
Lipopolysaccharides Upregulate Hepcidin in Neuron via Microglia and the IL-6/STAT3 Signaling Pathway
Qian, Z.-M., He, X., Liang, T., Wu, K.-C., Yan, Y.-C., Lu, L.-N., Yang, G., Luo, Q. Q., Yung, W.-H., & Ke, Y. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8671-3 · Cited by 89
“On the other hand, overexpression of hepcidin causes hypoferremia and anemia [11, 14, 15].”
BackgroundRoetto, A. (2004) · Blood · doi:10.1182/blood-2003-10-3390 · Cited by 89
Regulation of systemic iron homeostasis: how the body responds to changes in iron demand
Anderson, G. J., Darshan, D., Wilkins, S. J., & Frazer, D. M. (2007) · BioMetals · doi:10.1007/s10534-006-9030-2 · Cited by 120
“showed that iron loading in HFE null mice could be corrected by constitutively expressing hepcidin, confirming that HFE acts upstream of hepcidin in the iron regulatory pathway (Nicolas et al. 2003).”
BackgroundA variant erythroferrone disrupts iron homeostasis in SF3B1 -mutated myelodysplastic syndrome
Bondu, S., Alary, A.-S., Lefèvre, C., Houy, A., Jung, G., Lefebvre, T., Rombaut, D., Boussaid, I., Bousta, A., Guillonneau, F., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aav5467 · Cited by 85
Tmprss6 is a genetic modifier of the Hfe-hemochromatosis phenotype in mice
Finberg, K. E., Whittlesey, R. L., & Andrews, N. C. (2011) · Blood · doi:10.1182/blood-2010-10-315507 · Cited by 81
Viatte, L. (2006) · Blood · doi:10.1182/blood-2005-10-4071 · Cited by 85
The European Hematology Association Roadmap for European Hematology Research: a consensus document
Engert, A., Balduini, C., Brand, A., Coiffier, B., Cordonnier, C., Dohner, H., de Wit, T. D., Eichinger, S., Fibbe, W., Green, T., et al. (2016) · Haematologica · doi:10.3324/haematol.2015.136739 · Cited by 81
“European research groups established disease models for iron overload disorders to identify mechanisms that control iron balance.(184) These important research findings not only gave an insight into the classical iron-related disorders, but also significantly improved our knowledge of how iron accumulates and contribu…”
BackgroundLe Gac, G., Mons, F., Jacolot, S., Scotet, V., Férec, C., & Frébourg, T. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.04950.x · Cited by 81
“Other elements, such as HFE and the C/EBPa transcription factor, could also be implicated in the same iron-sensing pathway (Courselaud et al, 2002; Bridle et al, 2003; Muckenthaler et al, 2003; Nicolas et al, 2003).”
BackgroundHereditary iron overload: Update on pathophysiology, diagnosis, and treatment
Franchini, M. (2006) · American Journal of Hematology · doi:10.1002/ajh.20493 · Cited by 80
Myelodysplasia is in the niche: novel concepts and emerging therapies
Bulycheva, E., Rauner, M., Medyouf, H., Theurl, I., Bornhäuser, M., Hofbauer, L. C., & Platzbecker, U. (2015) · Leukemia · doi:10.1038/leu.2014.325 · Cited by 78
Metadata
- Authors
- Nicolas, G., Viatte, L., Lou, D.-Q., Bennoun, M., Beaumont, C., Kahn, A., Andrews, N. C., & Vaulont, S.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Vaulont, Sophie
- Venue
- Nature Genetics
- Published
- 2003-04-21
- Volume
- 34
- Issue
- 1
- Pages
- 97-101
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2018391935
- Cited by
- 311
- References
- 25
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 1 · 2023: 5 · 2022: 2 · 2021: 6 · 2020: 6 · 2019: 11 · 2018: 7 · 2017: 9 · 2016: 10 · 2015: 7 · 2014: 8 · 2013: 11 · 2012: 8
- FWCI
- 19.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Keywords
- hereditary hemochromatosis, hepcidin, HFE gene, Hfe knockout mice, iron overload, hyperferremia, hepatic iron deposition, intestinal iron absorption, reticuloendothelial cells, iron homeostasis
- MeSH terms
- Hemochromatosis Protein, Animals, Crosses, Genetic, Hemochromatosis, Humans, Membrane Proteins, Mice, Transgenic, Phenotype, RNA, Messenger, Histocompatibility Antigens Class I, Gene Expression, Mice, Knockout, Iron Overload, Mutation, Missense, Antimicrobial Cationic Peptides, Mice, Hepcidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.